https://www.selleckchem.com/products/A-966492.html
increase such interventions' availability are justified by the benefits to children and young people and the decreased likelihood of disorder in adulthood. Our objective was to assess the cost-effectiveness of novel rapid diagnostic tests rapid influenza diagnostic tests (RIDT), digital immunoassays (DIA), rapid nucleic acid amplification tests (NAAT), and other treatment algorithms for influenza in high-risk patients presenting to hospital with influenza-like illness (ILI). We developed a decision-analytic model to assess the cost-eff
Like
Comment
Share
